Cold Kit Formulation and Supply

The contract requires the manufacture and supply of sterile, FDA-approved cold kits that are non-radioactive reagent formulations designed to be compatible with Tc-99m generators used in nuclear medicine procedures at WBAMC. These kits must meet rigorous pharmaceutical standards to ensure safety, efficacy, and consistency in clinical settings, with strict adherence to FDA regulations for sterility, purity, and labeling. The products are intended for use in military medical facilities and must be produced under controlled conditions to maintain integrity throughout the supply chain. The contract is classified as a subcontract under NAICS code 325412, which pertains to pharmaceutical and biological product manufacturing, and is issued by the Department of Defense through its West Coast contracting office, W40M MRC0 West. Performance is designated for Fort Bliss, indicating that the kits will be utilized at or distributed from this military installation. The solicitation was posted on April 24, 2026, with a response deadline of May 8, 2026, at noon, requiring timely submission of technical and commercial proposals. All submitted solutions must demonstrate compliance with federal medical device and pharmaceutical guidelines and the ability to consistently deliver certified products to support operational medical needs.